Novel target for reducing flare in giant cell arteritis
An investigational monoclonal antibody that inhibits GM-CSF receptor alpha shows promise, researchers say
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/Senior_Woman_Tired_Headache_Tstock_1-1.jpg)
AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.
A new option for treating giant cell arteritis might be on the horizon, a conference has heard.